2020
DOI: 10.1007/s12325-020-01291-4
|View full text |Cite
|
Sign up to set email alerts
|

Intracranial Atherosclerotic Stenoses: Pathophysiology, Epidemiology, Risk Factors and Current Therapy Options

Abstract: Intracranial atherosclerotic stenoses (ICAS) are one of the most common causes of first and recurrent cerebrovascular ischaemic events worldwide, with highest prevalence in Asian, Hispanic and African populations. Clinical trials have improved the understanding of epidemiology, risk factors and imaging characteristics of patients with ICAS. Current therapeutic approaches concerning these patients include management of risk factors, best medical therapy, potentially endovascular and rarely surgical therapy. In … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0
4

Year Published

2021
2021
2023
2023

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 24 publications
(17 citation statements)
references
References 146 publications
(208 reference statements)
0
13
0
4
Order By: Relevance
“… 26 Furthermore, since acute large vessel occlusion in large-artery atherosclerosis is typically caused by an underlying unstable plaque, there is a high risk of reocclusion by subsequent platelet activation and recurrent thrombus formation, which might be addressed by permanent extra- or intracranial stenting and administration of blood thinners. 26 Moreover, cardioembolic thrombi are less likely to adhere to the site of vessel occlusion than in-situ thrombi, facilitating reperfusion. 27 However, this might be true for arterio-arterial embolic thrombi as well.…”
Section: Discussionmentioning
confidence: 99%
“… 26 Furthermore, since acute large vessel occlusion in large-artery atherosclerosis is typically caused by an underlying unstable plaque, there is a high risk of reocclusion by subsequent platelet activation and recurrent thrombus formation, which might be addressed by permanent extra- or intracranial stenting and administration of blood thinners. 26 Moreover, cardioembolic thrombi are less likely to adhere to the site of vessel occlusion than in-situ thrombi, facilitating reperfusion. 27 However, this might be true for arterio-arterial embolic thrombi as well.…”
Section: Discussionmentioning
confidence: 99%
“…ИКА служит непосредственной причиной каждого десятого ишемического инсульта у представителей белой расы [59]. Основные механизмы развития ИИ на фоне ИКА включают артериоартериальную эмболию, гипоперфузию и атероматоз перфорантов (Branch Atheromatous Disease), а также in situ тромбоз/окклюзию и нарушение вымывания эмболов из гипоперфузированной ткани [56,[60][61][62]. При этом у большинства больных имеют место изолированная гипоперфузия (35%) и комбинация гипоперфузии с артерио-артериальной эмболией (37%) [63].…”
Section: интракраниальный атеросклерозunclassified
“…ИКА не имеет специфического МРТ-паттерна очагов. Характер очагов зависит от подлежащего механизма и при выраженном ИКА включает 4 основных варианта: подкорковый очаг в зоне перфорантов (23-25%), территориальный (24-51%), в зоне смежного кровообраще- ния (9-52%) и смешанный [61,73]. Лакунарные инфаркты обнаруживаются у 10-19% пациентов и наиболее часто локализуются в варолиевом мосту, лучистом венце или полуовальном центре [56].…”
Section: интракраниальный атеросклерозunclassified
“…UU.) self-expanding stent for use under the exception of the humanitarian device in medically-refractory patients with TIA or CVA secondary to 50-99% stenosis of a major intracranial artery [52].…”
Section: Endovascular Treatmentmentioning
confidence: 99%